7Baggers
 Enlivex Therapeutics Announces Annual General Meeting for November 2025  The Globe and Mail Fri, 26 Sep 2025 21:10:00 GMT
 ENLV: D. Boral Capital Maintains Buy Rating with $13 Price Targe  GuruFocus Fri, 26 Sep 2025 12:09:59 GMT
 Enlivex Therapeutics schedules annual general meeting for November 10  Investing.com Thu, 25 Sep 2025 20:55:22 GMT
 published on: 2025-09-21 05:52:00  newser.com Sun, 21 Sep 2025 10:52:00 GMT
 published on: 2025-09-19 05:21:33  خودرو بانک Fri, 19 Sep 2025 01:55:46 GMT
 published on: 2025-09-16 16:43:52  newser.com Tue, 16 Sep 2025 21:43:52 GMT
 Will Enlivex Therapeutics (NASDAQ:ENLV) Spend Its Cash Wisely?  Yahoo Finance Sun, 14 Sep 2025 07:00:00 GMT
 ENLV Stock: D. Boral Capital Maintains Buy Rating and $13 PT | E  GuruFocus Fri, 12 Sep 2025 07:00:00 GMT
 enlivex therapeutics (enlv) secures israeli patent for osteoarth  GuruFocus Tue, 09 Sep 2025 12:21:07 GMT
 Enlivex Secures Israeli Patent for Osteoarthritis Treatment  TipRanks Tue, 09 Sep 2025 07:00:00 GMT
 knee osteoarthritis market to expand significantly by 2034,  openPR.com Mon, 08 Sep 2025 14:30:06 GMT
 published on: 2025-09-05 16:48:27  خودرو بانک Fri, 05 Sep 2025 13:20:25 GMT
 hc wainwright has bullish estimate for enlv q3 earnings  Defense World Fri, 05 Sep 2025 05:34:21 GMT

Enlivex Therapeutics Ltd
(NASDAQ:ENLV) 

ENLV stock logo

Enlivex Therapeutics Ltd. operates as a clinical stage macrophage reprogramming immunotherapy company. It is developing Allocetra, an off-the-shelf cell therapy designed to reprogram macrophages into homeostatic state. Resetting non-homeostatic macrophages into homeostatic state is critical for immu...

Founded: 2005
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends